Pierre Vandepapelière – CEO
“As the CEO of Amyl Therapeutics, my role is to lead with vision, passion, and purpose. In a field as challenging as neurodegeneration, every decision brings us closer to potential breakthroughs that could one day impact the lives of patients, families, and communities. I’m proud to lead a team that’s committed to transforming lives and advancing science.”
Damien Toulorge – CSO
“As the CSO of Amyl Therapeutics, my role is to define the scientific strategy, prioritize research areas, and ensure the progress of the projects.
I lead the scientific team, facilitating the exchange of ideas and optimizing resources to ensure solid and innovative results.
My role also involves maintaining constant communication with the CEO to align scientific objectives with the company’s overall vision.”
Christophe Mathieu – CFO
“As the CFO of Amyl Therapeutics, I work closely with the CEO and CSO to understand the financial needs of the studies and ensure that we stay within budget.
Together, we align financial strategies with the company’s vision and research priorities.
I also manage all financial, accounting, tax and corporate aspects of the Company, all while navigating a complex and ever-changing environment.”
Julie Goemaere – R&D Director
“As R&D director at Amyl Therapeutics, I support my team in developing products from proof of concept to pre-clinical evidence, always keeping patients’ needs in mind.
Every day, I’m inspired by the challenge of transforming medical needs into tangible solutions.
Together, we stay creative, innovate, and push the boundaries to make a meaningful impact on patients’ lives.”
Elodie Hendrick – R&D Laboratory Manager
“As R&D Lab Manager at Amyl Therapeutics, I oversee daily lab operations, ensuring efficient research activities.
I am responsible of training and managing staff, ensuring safety and regulatory compliance, and managing lab budgets and resources.
I work closely with the R&D Director and Senior Project Manager to streamline workflows, manage timelines, and achieve R&D goals while maintaining high operational standards.”
Aditya Iyer – Senior Project Manager
“As Senior Project Manager at Amyl Therapeutics, I lead bold experiments and manage collaborations with CROs.
My days blend science, strategy, and curiosity—pushing boundaries, challenging existing ideas to bring hope to those affected by Alzheimer’s and Parkinson’s.
I work closely with the R&D Director and CSO to align on R&D strategy, write grants, prepare public presentations, and prioritize research initiatives to drive our mission forward.”
Dafni Birmpili – R&D Project Associate
“As R&D Project Associate, my role involves collaborating with the R&D Director and the project manager to define the project planning and strategy.
I am providing expert support for specific activities such as candidate-drug expression, optimization studies, and method development.
I am also ensuring the timely collection and communication of data with third parties and with scientists in the team.”
Chiara Vollaro & Sandra Parys – R&D Lab Associate Scientists
“As R&D Lab Associate Scientist at Amyl Therapeutics, we are responsible for executing and analyzing lab experiments.
We ensure accurate data recording, participate in interpreting and communicating scientific data in collaboration with the R&D laboratory manager, and we contribute to the development and refinement of new methods.”
Sophia Maniscalchi – Admin. & Communication Assistant
“As the Admin. & Communication Assistant, I am the “Swiss knife” of the company.
I provide diverse administrative support to all the team, including payroll management, conference and travel organization, presentations, invoicing, and organization of team events.
In addition, I develop communication strategies to promote the company’s image, writing content for LinkedIn and updating the website.”
